128 related articles for article (PubMed ID: 9486917)
1. Neutrophil 5-nucleotidase reaction in chronic myelogenous leukemia, myelofibrosis with myeloid metaplasia, and polycythemia vera.
Tsavaris NB; Pangalis GA
Ann Hematol; 1998 Jan; 76(1):1-5. PubMed ID: 9486917
[TBL] [Abstract][Full Text] [Related]
2. Myeloperoxidase-deficient polymorphonuclear leucocytes (VII): Incidence in untreated myeloproliferative disorders.
Bendix-Hansen K
Scand J Haematol; 1986 Jan; 36(1):8-10. PubMed ID: 3006224
[TBL] [Abstract][Full Text] [Related]
3. Mobilization of granules in neutrophils from patients with myeloproliferative disorders.
Borregaard N; Kjeldsen L; Sengeløv H
Eur J Haematol; 1993 Apr; 50(4):189-99. PubMed ID: 8388806
[TBL] [Abstract][Full Text] [Related]
4. Comparison of erythroid progenitor cell growth in vitro in polycythemia vera and chronic myelogenous leukemia: only polycythemia vera has endogenous colonies.
Weinberg RS; Worsley A; Gilbert HS; Cuttner J; Berk PD; Alter BP
Leuk Res; 1989; 13(4):331-8. PubMed ID: 2716348
[TBL] [Abstract][Full Text] [Related]
5. Neutrophil alkaline phosphatase: comparison of enzymes from normal subjects and patients with polycythemia vera and chronic myelogenous leukemia.
Rosenblum D; Petzold SJ
Blood; 1975 Mar; 45(3):335-43. PubMed ID: 46759
[TBL] [Abstract][Full Text] [Related]
6. [Results of selected cytochemical studies of mature granulocytes in myelodysplastic syndromes and various other hematologic diseases].
Mariańska B; Apel D; Maj S
Acta Haematol Pol; 1991; 22(1):54-7. PubMed ID: 1823968
[TBL] [Abstract][Full Text] [Related]
7. Monocyte induces alkaline phosphatase synthesis in neutrophils of chronic myeloid leukemia and myelofibrosis with myeloid metaplasia patients.
Chikkappa G; Pasquale DT; Wang GJ; Santella D
Am J Clin Pathol; 1989 May; 91(5):550-7. PubMed ID: 2718954
[TBL] [Abstract][Full Text] [Related]
8. Pathogenetic mechanisms in chronic myeloproliferative disorders: polycythemia vera, essential thrombocythemia, agnogenic myeloid metaplasia, and chronic myelogenous leukemia.
Tefferi A
Semin Hematol; 1999 Jan; 36(1 Suppl 2):3-8. PubMed ID: 9930550
[TBL] [Abstract][Full Text] [Related]
9. Serum phospholipase A in hematological diseases.
Hiefinger RT; Guder WG; Hoffmann GE
Klin Wochenschr; 1989 Feb; 67(3):222-4. PubMed ID: 2927059
[TBL] [Abstract][Full Text] [Related]
10. JAK-2 V617F mutation increases heparanase procoagulant activity.
Kogan I; Chap D; Hoffman R; Axelman E; Brenner B; Nadir Y
Thromb Haemost; 2016 Jan; 115(1):73-80. PubMed ID: 26489695
[TBL] [Abstract][Full Text] [Related]
11. [Neutrophil alkaline phosphatase score].
Nakamura Y; Waga K; Mitani K
Nihon Rinsho; 2004 Dec; 62 Suppl 12():785-8. PubMed ID: 15658450
[No Abstract] [Full Text] [Related]
12. Chemiluminescence of neutrophils in patients with myeloproliferative or myelodysplastic hematologic diseases--relation to neutrophil alkaline phosphatase activity.
Wakita H; Asai T; Oh H; Itoh K; Yoshida S
Intern Med; 1993 Mar; 32(3):204-9. PubMed ID: 7687168
[TBL] [Abstract][Full Text] [Related]
13. MYELOPROLIFERATIVE SYNDROME; EVALUATION OF MYELOSCLEROSIS AND CHRONIC MYELOGENOUS LEUKEMIA TO POLYCYTHEMIA VERA.
LOPAS H; JOSEPHSON AM
Arch Intern Med; 1964 Dec; 114():754-9. PubMed ID: 14211587
[No Abstract] [Full Text] [Related]
14. Bone marrow biopsy (BMB). II. Bone marrow biopsy in myeloproliferative disorders.
Macavei I; Galatâr N
Morphol Embryol (Bucur); 1989; 35(2):117-27. PubMed ID: 2529429
[TBL] [Abstract][Full Text] [Related]
15. [Hypocholesterolemia and other lipoprotein disorders in myelofibrosis].
Kiss A; Telek B; Rák K
Orv Hetil; 1994 Nov; 135(48):2643-6. PubMed ID: 7808738
[TBL] [Abstract][Full Text] [Related]
16. [ENERGY METABOLISM OF HUMAN THROMBOCYTES UNDER NORMAL CONDITIONS AND IN POLYCYTHEMIA AND CHRONIC MYELOSIS].
EGOROVA VA; BLINOVA AI; SEITS IF
Vopr Med Khim; 1965; 11():35-41. PubMed ID: 14339546
[No Abstract] [Full Text] [Related]
17. Circulating erythroid progenitors in patients with 'spent' polycythaemia vera and myelofibrosis with myeloid metaplasia.
Kornberg A; Fibach E; Treves A; Goldfarb A; Rachmilewitz EA
Br J Haematol; 1982 Dec; 52(4):573-8. PubMed ID: 7138787
[TBL] [Abstract][Full Text] [Related]
18. Molecular genetic evaluation of myeloproliferative neoplasms.
Azzato EM; Bagg A
Int J Lab Hematol; 2015 May; 37 Suppl 1():61-71. PubMed ID: 25976962
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of neutrophil alkaline phosphatase (NAP) activity in untreated myeloproliferative syndromes and in leukaemoid reactions.
Bendix-Hansen K; Bergmann OJ
Scand J Haematol; 1985 Aug; 35(2):219-24. PubMed ID: 4048868
[TBL] [Abstract][Full Text] [Related]
20. The role of beta-catenin in chronic myeloproliferative disorders.
Jauregui MP; Sanchez SR; Ewton AA; Rice L; Perkins SL; Dunphy CH; Chang CC
Hum Pathol; 2008 Oct; 39(10):1454-8. PubMed ID: 18619646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
